Breaking barriers and “having it all,” empowerment and success — topics uniquely relevant to women are getting a spotlight this Thursday and Friday at the S.H.E. Summit in New York. For two full days, founder Claudia Chan is bringing together over 60 speakers and thought leaders — UN ambassador Samantha Power, journalist Mariane Pearl and Wall Street powerhouse Sallie Krawcheck among them — to parse through everything most relevant to the modern woman today, from leadership and innovation to self care, motherhood and wealth management.

Preview the event in the video above — and tune in Thursday and Friday on the livestream here.

More to explore in Culture


  • hiker salike

    is a great pastime hobby for outdoor enthusiasts who enjoy being close to
    nature. thanks share the post Hiking
    shoes reviews

  • Yang Lin

    Pfizer R & D line and added two varieties of antibiotics

    Pfizer announced on June 16 , Pfizer and Vicuron signed a merger agreement to acquire .Posaconazole hydrate, Vicuron is a biopharmaceutical company dedicated to the development community for the anti- hospital infections and infections innovative anti-infectives .

    Pfizer to obtain the Vicuron ‘s drug development projects. Vicuron company currently has two products NDA application subject to review at the FDA : antifungal anidulafungin and anti- Gram-positive cocci infection antibiotic dalbavancin. Recently , Vicuron announced the results of anidulafungin Phase III clinical trials , the results in Table Minge Kniffen net than fluconazole (Fluconazole) is more suitable for invasive candidiasis.Terbinafine , Anidulafungin potential product features will include anti- Aspergillus niger and Candida fungal infections most broad-spectrum activity. The product is expected to once a day medication period of up to one month.

    Dalbavancin good results in Phase III complicated skin and soft tissue infections and bloodstream research study catheter-related infections in the second period displayed . The product once-weekly dosing .Fluconazole , Vicuron recently announced that the company ‘s NDA application for dalbavancin to get a three-month priority review extended period. FDA ‘s review is expected to be completed by September 21, 2005 . Observers have predicted its annual sales will peak over 200 million U.S. dollars , Fluconazole hydrate,which is specifically designed to improve the widely used version of Pfizer’s antibiotic vancomycin .

    Pfizer’s president, said : ” By acquiring Vicuron, we can help to bring two very important new medicines Pfizer Global Patient transaction in respect of anti-infective products more abundant,Fluconazole mesylate , but also demonstrates our commitment to strengthen and through acquisitions. expand our scope of business . ”

    Medchemexpress Can provide the above product,its website: